Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment.
We report the first case of an HIV negative patient with gastric Kaposi's sarcoma (KS) and peritoneal carcinomatosis in whom a complete response (CR) was obtained after liposomal daunorubicin administration. The patient presented with epigastric pain and hematemesis. Upper gastric endoscopy with multiple biopsies showed gastric involvement by KS. The whole physical examination and the thoraco-abdomino-pelvic CT scans showed no other localization. A total gastrectomy was performed. Histological examination confirmed the diagnosis of KS with involvement of regional lymph nodes and peritoneal lesions. Six cycles of liposomal daunorubicin were given. Post-treatment coelioscopic control was normal. The patient received another six adjuvant cycles of liposomal daunorubicin. The patient is in complete remission six months after the end of treatment. Liposomal daunorubicin is a promising treatment in the non HIV patient with visceral KS.
Fléchon
A
A
Oncologie Médicale, H pital Edouard Herriot, Lyon, France.
Lombard-Bohas
C
C
Boulez
J
J
Blay
J Y
JY
Scoazec
J Y
JY
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy* / Q000209:etiology; D003630:Daunorubicin / Q000008:administration & dosage*; D018023:HIV Seronegativity; D006801:Humans; D008081:Liposomes; D008297:Male; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000209:etiology; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000209:etiology
D000903:Antibiotics, Antineoplastic; D008081:Liposomes; D003630:Daunorubicin